The company will still have some catching up to do, as LM-299 is early in clinical development, with a phase 1 trial ...

BioNTech, the German developer of a widely used mRNA vaccine for the coronavirus, agreed to pay US$800 million (HK$6.24 ...

The deal is set for completion in Q1 2025. Credit: afotostock via Shutterstock. BioNTech has signed a definitive agreement to ...

Frankfurt/Main (dpa) - Mainz bleibt einer Studie zufolge auch im dritten Jahr hintereinander die dynamischste Großstadt in ...

Hinweis: Informationen zur Offenlegungspflicht bei Interessenkonflikten im Sinne von § 85 Abs. 1 WpHG, Art. 20 VO (EU) 596/2014 für das genannte Analysten-Haus ...

BioNTech is shelling out $800 million upfront to acquire China-based Biotheus in a move that would give it access to a ...

BioNTech SE (BNTX) has released an update. BioNTech SE is set to acquire Biotheus in a deal valued at $800 million, aiming to strengthen its ...

On Wednesday, BioNTech SE (NASDAQ:BNTX) agreed to acquire Biotheus, a clinical-stage biotechnology company focused on ...

Im Kampf gegen Krebs wagt Biontech die größte Transaktion der Firmengeschichte. Die Übernahme von Biotheus ist für die ...

BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid ...

Biontech erweitert seine Pipeline an Krebsmedikamenten mit einem bis zu knapp eine Milliarde Dollar schweren Zukauf. Für die ...

German drugmaker to use state-of-art antibody in tandem with advanced therapies to more effectively fight cancer, detect ...